addS

Monday, 31 March 2014

Smoking Cessation And Nicotine De-Addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-Cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Smoking Cessation And Nicotine De-Addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-Cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Smoking de-addiction is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

Browse Full Report With TOC:
http://www.marketresearchreports.biz/analysis-details/smoking-cessation-and-nicotine-de-addiction-products-market-nicotine-gums-patches-lozenges-inhalers-sprays-sublingual-tablets-zyban-chantixchampix-e-cigarettes-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019

This report studies the global smoking cessation and nicotine de-addiction products market from the perspective of various product types available in the market. These include nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia Pacific and Rest of the World (RoW).

Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size.

Browse Full Report With TOC:
http://www.marketresearchreports.biz/sample/sample/192907

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 List of Abbreviations
1.3.4 Assumptions and Stipulations

Chapter 2 Executive Summary

Chapter 3 Global Smoking Cessation and Nicotine De-addiction Market Overview
3.1 Market Definition and Overview
3.1.1 Nicotine Consumption, Prevalence And Trends
3.1.2 Smoking Health Hazards
3.2 R&D Pipeline
3.3 Combination Therapy for Smoking Cessation/Nicotine De-addiction
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.1.1 Rising Awareness about Smoking Health Hazards and Smoking Cessation Therapy
3.4.1.2 Government intervention for smoking de-addiction
3.4.1.3 Introduction of new products will expand the market
3.4.1.4 Reimbursement for smoking cessation therapy
3.4.2 Restraints
3.4.2.1 Low awareness about smoking cessation products in the developing economies
3.4.2.2 Legal obligations dragging growth of several smoking cessation product segments
3.4.3 Opportunities
3.4.3.1 Research and Development
3.4.3.2 Market Expansion
3.5 Porter’s Five Forces Analysis for the Global Smoking Cessation and Nicotine De-addiction Products Market
3.5.1 Bargaining Power Of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat from New Entrants
3.5.4 Threat from Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography

To Get Download Full Report with TOC:
http://www.marketresearchreports.biz/analysis/192907 

Chapter 4 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type
4.1 Introduction
4.1.1 Global Smoking Cessation and Nicotine De-addiction Products Market, by Product Type, 2011 - 2019 (USD Million)
4.2 Nicotine Replacement Therapy Products
4.2.1 Global Nicotine Replacement Therapy Products Market Revenue, 2011 - 2019 (USD Million)
4.2.1 Nicotine Gums
4.2.1.1 Global Nicotine Gums Market Revenue, 2011 - 2019 (USD Million)
4.2.2 Nicotine Transdermal Patches
4.2.2.1 Global Nicotine Transdermal Patches Market Revenue, 2011 - 2019 (USD Million)
4.2.3 Nicotine Lozenges
4.2.3.1 Global Nicotine Lozenges Market Revenue, 2011 - 2019 (USD Million)
4.2.4 Nicotine Sprays
4.2.4.1 Global Nicotine Sprays Market Revenue, 2011 - 2019 (USD Million)
4.3 Nicotine Inhalers
4.3.1 Global Nicotine Inhalers Market Revenue, 2011 - 2019 (USD Million)
4.4 Nicotine Sublingual Tablets

Contact US:  

Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

No comments:

Post a Comment